Wire · opportunities
FDA Approves Ryzumvi Eye Drops for Presbyopia
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 19 October 2026 · Fusion42 review
The FDA approved Ryzumvi eye drops containing 0.75% phentolamine for treating presbyopia in adults, marking the first pharmacologic eye drop option to improve near vision by inducing pupillary constriction. The drug, marketed by Viatris under exclusive US rights, was previously approved for pharmacologically induced mydriasis and is now indicated for age-related presbyopia with known side effects like conjunctival hyperemia and instillation-site irritation.
This Wire brief sits within Fusion42's coverage of Medtech, and 4 sources have reported it between 17 Oct 2026 and 19 Oct 2026.
◆ ◆ The Wire takeaway
You have a new route to treat presbyopia without glasses in the US. If your product addresses age-related vision issues, this approval shifts patient and provider expectations around pharmacologic eye care.
◆ Coverage
4 sources · first reported 17 Oct 2026 · latest 19 Oct 2026
◆ Related on Wire
◆ Topics